AAAAAA
Results:
1-14
|
Results: 14
Authors:
MYERS LA
RIESTER DE
SCHIFF RI
SCHIFF SE
WILLIAMS LW
ROBERTS JL
PUCK JM
BUCKLEY RH
Citation: La. Myers et al., BONE-MARROW TRANSPLANTATION FOR SCID IN THE NEONATAL-PERIOD, Journal of allergy and clinical immunology, 99(1), 1997, pp. 411-411
Authors:
HARTMAN HA
MYERS LA
EVANS M
ROBISON RL
ENGSTROM RG
TSE FLS
Citation: Ha. Hartman et al., THE SAFETY EVALUATION OF FLUVASTATIN, AN HMG-COA REDUCTASE INHIBITOR,IN BEAGLE DOGS AND RHESUS-MONKEYS, Fundamental and applied toxicology, 29(1), 1996, pp. 48-62
Authors:
MYERS LA
BOYCE JT
ROBISON RL
Citation: La. Myers et al., THE TOLERABILITY AND PHARMACOLOGY OF INTERLEUKIN-6 ADMINISTERED IN COMBINATION WITH GM-CSF OR G-CSF IN THE RHESUS-MONKEY, Toxicology, 101(3), 1995, pp. 157-166
Authors:
HUHN RD
YURKOW EJ
KUHN JG
CLARKE L
GUNN H
RESTA D
SHAH R
MYERS LA
SEIBOLD JR
Citation: Rd. Huhn et al., PHARMACODYNAMICS OF DAILY SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 32-41
Authors:
FARESE AM
MYERS LA
MACVITTIE TJ
Citation: Am. Farese et al., THERAPEUTIC EFFICACY OF THE COMBINED ADMINISTRATION OF EITHER RECOMBINANT HUMAN (RH) INTERLEUKIN-6 AND RHGRANULOCYTE COLONY-STIMULATING FACTOR OR RHGRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PRIMATEMODEL OF RADIATION-INDUCED MARROW APLASIA, Experimental hematology, 22(8), 1994, pp. 684-684
Authors:
HUHN RD
SORANNO T
GUNN H
SHAH R
YURKOW EJ
MYERS LA
SEIBOLD JR
Citation: Rd. Huhn et al., PHARMACOKINETICS OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 (RHIL-3) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 190-190
Authors:
MACVITTIE TJ
FARESE AM
PATCHEN ML
MYERS LA
Citation: Tj. Macvittie et al., THERAPEUTIC EFFICACY OF RECOMBINANT INTERLEUKIN-6 (IL-6) ALONE AND COMBINED WITH RECOMBINANT HUMAN IL-3 IN A NONHUMAN PRIMATE MODEL OF HIGH-DOSE, SUBLETHAL RADIATION-INDUCED MARROW APLASIA, Blood, 84(8), 1994, pp. 2515-2522
Authors:
FARESE AM
MYERS LA
MACVITTIE TJ
Citation: Am. Farese et al., THERAPEUTIC EFFICACY OF RECOMBINANT HUMAN LEUKEMIA INHIBITORY FACTOR IN A PRIMATE MODEL OF RADIATION-INDUCED MARROW APLASIA, Blood, 84(11), 1994, pp. 3675-3678
Authors:
WINTON EF
SRINIVASIAH J
KIM BK
HILLYER CD
STROBERT EA
ORKIN JL
SWENSON RB
MCCLURE HM
MYERS LA
SARAL R
Citation: Ef. Winton et al., EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6) AND RHIL-3 ON HEMATOPOIETIC REGENERATION AS DEMONSTRATED IN A NONHUMAN PRIMATE CHEMOTHERAPY MODEL, Blood, 84(1), 1994, pp. 65-73
Authors:
MACVITTIE TJ
FARESE AM
PATCHEN ML
MYERS LA
Citation: Tj. Macvittie et al., COMPARATIVE THERAPEUTIC EFFICACY OF COMBINATION RECOMBINANT HUMAN IL-6 AND IL-3 CYTOKINE PROTOCOLS IN A PRIMATE MODEL OF RADIATION-INDUCED MARROW APLASIA, Experimental hematology, 21(8), 1993, pp. 1171-1171
Authors:
TOMER A
STAHL CP
MCCLURE HM
ANDERSON DC
MYERS LA
LIEHL E
WINTON EF
Citation: A. Tomer et al., EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON PLATELET SURVIVAL AND ACTIVATION USING A NONHUMAN PRIMATE MODEL, Experimental hematology, 21(12), 1993, pp. 1577-1582
Authors:
GONTER PW
HILLYER CD
STROBERT EA
ORKIN JL
SWENSON RB
MCCLURE HM
MYERS LA
WINTON EF
Citation: Pw. Gonter et al., ENHANCED POSTCHEMOTHERAPY PLATELET AND NEUTROPHIL RECOVERY USING COMBINATION RHIL-6 AND RHGM-CSF OR RHG-CSF IN A NONHUMAN PRIMATE MODEL, Blood, 82(10), 1993, pp. 10000365-10000365
Authors:
GONTER PW
HILLYER CD
STROBERT EA
ORKIN JL
SWENSON RB
MCCLURE HM
MYERS LA
WINTON EF
Citation: Pw. Gonter et al., THE EFFECT OF VARYING RATIOS OF ADMINISTERED RHIL-3 AND RHGM-CSF ON POSTCHEMOTHERAPY MARROW REGENERATION IN A NONHUMAN PRIMATE MODEL, Blood, 82(10), 1993, pp. 10000365-10000365
Authors:
HUHN RD
YURKOW EJ
CLARKE L
RESTA D
SORANNO T
SEIBOLD JR
MYERS LA
Citation: Rd. Huhn et al., CLINICAL AND HEMATOPOIETIC EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-3ADMINISTERED BY DAILY SUBCUTANEOUS INJECTION TO HEALTHY NORMAL VOLUNTEERS, Blood, 82(10), 1993, pp. 10000500-10000500
Risultati:
1-14
|